DC Field | Value | Language |
dc.contributor.author | Lacusta, Alina | - |
dc.date.accessioned | 2020-07-06T11:57:56Z | - |
dc.date.available | 2020-07-06T11:57:56Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | LACUSTA, Alina. Breathe new life into chronic kidney disease. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 182-183. | en_US |
dc.identifier.uri | https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf | - |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/11003 | - |
dc.description | Department of pathophysiology
and clinical pathophysiology,
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova | en_US |
dc.description.abstract | Introduction. Chronic kidney disease (CKD) is a worldwide public problem. There is a rising
incidence and prevalence of kidney failure with poor outcomes and high cost. The guidelines
define CKD as kidney damage or decreased glomerular filtration rate (GFR) less than 60
mL/min/1.73m2 for at least 3 months. In Moldova, there were registered 490 patients with
chronic kidney disease in 2017. Nowadays, dialysis and transplantation are 2 main solutions
especially in end-stage kidney disease. Dialysis will prolong the life, but they will not have a
normal life quality. Life expectancy of someone on dialysis is lower than that of the general
population. Dialysis and transplantation are not fully available for all patients.
Aim of the study. Analysis and comparing the data of latest studies performed in Europe and
USA regarding new approach of CKD treatment, including exploring the field of artificial
kidney grown in laboratories.
Materials and methods. The principle of this study execution consists on exploring of different
new and suitable methods of treatment and life quality improvement in patients with CKD.
Meta-analysis of diverse studies is the key tool for disclosure of optimal strategies for kidney
function improvement in the ends stage of diseases.
Results. 1. Regenerative medicine holds the potential to fully heal damaged tissues and organs,
offering solutions and hope for people who have conditions that today are beyond repair. 2. A
new drug therapy that could potentially control protein leakage from the kidneys. 3. A new
approach to prevent the kidney cell irreversible injury: AC1903. 4. Scientists have successfully
produced human kidney tissue within a living organism, which is able to produce urine.
Conclusions. The outcome of the study reveals a significant "win" on kidney disease. In
Moldova patients reach late stages of chronic renal disease, because a lot them are addressing too
late to medical care services. That’s why new treatment methods have a great importance to save
lives of patients with CKD and to improve their life quality as well. | en_US |
dc.language.iso | en | en_US |
dc.publisher | MedEspera | en_US |
dc.subject | Chronic kidney disease (CKD) | en_US |
dc.subject | chronic renal failure | en_US |
dc.subject | therapeutic methods | en_US |
dc.title | Breathe new life into chronic kidney disease | en_US |
dc.type | Article | en_US |
Appears in Collections: | MedEspera 2018
|